Patented Murnia™ Molecular Compound
Our patented biotechnology platform transforms scientific research into clinically validated healthcare technologies for the protection, regeneration and restoration of skin and mucosal tissues.
Patented Regenerative Biotechnology Platform
Murnia® is built upon Umayana Biotechnology’s patented molecular platform developed to protect, regenerate and restore skin and mucosal tissues.
Patent Portfolio
- 🌍 WO2020072987
- 🇺🇸 US Patent 11,331,360 B2
- 🇪🇺 EP3860633 B1
🧬 Mechanism of Action
Murnia® forms a bioactive protective layer while supporting the regenerative processes of the underlying tissue. Its optimized bioadhesive technology enables prolonged contact with skin and mucosal surfaces, creating an ideal environment for tissue repair.
Scientifically Validated Regenerative Activity
Laboratory studies demonstrate that the patented Murnia® molecular platform supports tissue regeneration by stimulating genes involved in extracellular matrix remodeling and skin repair.
Validated biological activities
✔ Antioxidant activity
✔ Protection against oxidative stress
✔ Tissue regenerative activity
✔ Collagen and elastin synthesis support
Clinical Evidence in Oncology Supportive Care
Clinical evaluation of Murnia® Mouth Gel demonstrated a significant reduction in the severity of oral mucositis in patients receiving radiotherapy for head and neck cancer.
Presented at:
- International Academy of Oral Oncology (IAOO), Rome (2019)
- MASCC/ISOO Annual Meeting, Toronto (2022)
- International Radiation Oncology Congress, Türkiye (2023)
Clinical Outcome
While all patients in the placebo group developed Grade 3 oral mucositis by Week 3, none of the patients treated with Murnia® Mouth Gel experienced Grade 3 mucositis, allowing uninterrupted completion of radiotherapy.
Clean & Bio-Based Formulation
At Umayana Biotechnology, we intentionally formulate without petroleum-derived ingredients that may negatively impact skin, mucosal tissues or the environment.
All formulations are evaluated by accredited independent laboratories for safety and biocompatibility.
This commitment to sustainable innovation has also been recognized through Umayana’s participation in the United Nations Global Cleantech Innovation Programme (UN GCIP).